Topic Review
Diabetes Mellitus Type 2
Diabetes mellitus type 2 (also known as type 2 diabetes) is a long-term metabolic disorder that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, and unexplained weight loss. Symptoms may also include increased hunger, feeling tired, and sores that do not heal. Often symptoms come on slowly. Long-term complications from high blood sugar include heart disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon. Type 2 diabetes primarily occurs as a result of obesity and lack of exercise. Some people are more genetically at risk than others. Type 2 diabetes makes up about 90% of cases of diabetes, with the other 10% due primarily to diabetes mellitus type 1 and gestational diabetes. In diabetes mellitus type 1 there is a lower total level of insulin to control blood glucose, due to an autoimmune induced loss of insulin-producing beta cells in the pancreas. Diagnosis of diabetes is by blood tests such as fasting plasma glucose, oral glucose tolerance test, or glycated hemoglobin (A1C). Type 2 diabetes is partly preventable by staying a normal weight, exercising regularly, and eating properly. Treatment involves exercise and dietary changes. If blood sugar levels are not adequately lowered, the medication metformin is typically recommended. Many people may eventually also require insulin injections. In those on insulin, routinely checking blood sugar levels is advised; however, this may not be needed in those taking pills. Bariatric surgery often improves diabetes in those who are obese. Rates of type 2 diabetes have increased markedly since 1960 in parallel with obesity. As of 2015 there were approximately 392 million people diagnosed with the disease compared to around 30 million in 1985. Typically it begins in middle or older age, although rates of type 2 diabetes are increasing in young people. Type 2 diabetes is associated with a ten-year-shorter life expectancy. Diabetes was one of the first diseases described. The importance of insulin in the disease was determined in the 1920s.
  • 812
  • 28 Sep 2022
Topic Review
Lung Fibrosis after COVID-19
The incidence rate of post-COVID lung fibrosis can be estimated at 2–6% after a moderate illness. According to this estimation, the prevalence of post-COVID lung fibrosis will be from 10 to 30 patients per 10,000 populations, which is 30 times higher than the IPF prevalence.
  • 812
  • 08 Sep 2021
Topic Review
ADAM 17 and Epithelial-to-Mesenchymal Transition
For decades, metalloproteinase 17 (ADAM17) has been the goal of wide investigation. Since its discovery as the tumour necrosis factor-α convertase, it has been studied as the main drug target, especially in the context of inflammatory conditions and tumour. In fact, evidence is mounting to support a key role of ADAM17 in the induction of the proliferation, migration and progression of tumour cells and the trigger of the pro-fibrotic process during chronic inflammatory conditions; this occurs, probably, through the activation of epithelial-to-mesenchymal transition (EMT). EMT is a central morphologic conversion that occurs in adults during wound healing, tumour progression and organ fibrosis. EMT is characterised by the disassembly of cell–cell contacts, remodelling of the actin cytoskeleton and separation of cells, and generates fibroblast-like cells that express mesenchymal markers and have migratory properties. This transition is characterised by loss of epithelial proteins such as E-cadherin and the acquisition of new mesenchymal markers, including vimentin and a-smooth muscle actin.
  • 808
  • 03 Aug 2021
Topic Review
Iron in Porphyrias
Despite the strict link between iron and heme, the role of iron in the different types of porphyrias, particularly as a risk factor for disease development/progression or as a potential therapeutic target or molecule, is still being debated, since contrasting results have emerged from clinical observations, in vitro studies and animal models.
  • 797
  • 28 Jan 2022
Topic Review
Gene Therapy in PolyQ SCAs
Polyglutamine spinocerebellar ataxias (PolyQ SCAs) are a group of 6 rare autosomal dominant diseases, which arise from an abnormal CAG repeat expansion in the coding region of their causative gene. These neurodegenerative ataxic disorders are characterized by progressive cerebellar degeneration, which translates into progressive ataxia, the main clinical feature, often accompanied by oculomotor deficits and dysarthria. Currently, PolyQ SCAs treatment is limited only to symptomatic mitigation, and no therapy is available to stop or delay the disease progression, which culminates with death.
  • 796
  • 27 Apr 2021
Topic Review
Morita Therapy
Morita therapy is an ecological, purpose-centered, response-oriented therapy created through case-based research by Shoma Morita, M.D. (1874–1938). Morita developed his theory of consciousness and medically-grounded four-stage progressive therapeutic method with rigor. The goal of Morita therapy is to have the patient accept life as it is. This does not mean that the patient cannot set and achieve goals, but be able to be satisfied with their life in the moment. Morita therapy places an emphasis on letting nature take its course. This is not to say that patients should be resigned to their mental illness but to respect the laws of nature. Feeling emotions is a law of nature according to Morita therapy. Morita therapy helps its patients understand that experiencing emotions, positive or negative, is a facet of being a human being. Morita describes his own therapy as follows: Morita therapy was originally developed to address shinkeishitsu, an outdated term used in Japan to describe patients who have various types of anxiety. Morita therapy was designed not to completely rid the patient of shinkeishitsu but to lessen the damaging effects. While Morita therapy has been described as cognate to Albert Ellis's rational-emotive therapy, this description does not account for the ecological foundation of the therapy. Morita therapy also has commonalities with existential and cognitive behavioral therapy.
  • 795
  • 10 Nov 2022
Topic Review
Food-Derived Protease Inhibitors
Plant protease inhibitors (PI) are usually small water-soluble proteins having many roles in the host biology, and they appear widely in the plant kingdom. Among many other functions in plant physiology, PIs are components of plants’ defensive systems. PIs protect plants against pathogens and also against herbivores; thus, several classes of PIs inhibiting mammal and insect digestive enzymes are often expressed in many plant tissues. PIs are present in many common food and feed plants. Many plant-derived PIs, such as Bowman-Birk inhibitors and Kunitz-type inhibitors, have been suggested to negatively affect dietary protein digestion by blocking the activity of trypsin and chymotrypsin in the human gastrointestinal system. In addition, some PIs may possess proinflammatory activities. However, there is also scientific evidence on some beneficial effects of PIs, for example, gut-related anti-inflammatory and chemopreventive activities in vitro and in vivo.
  • 786
  • 12 Oct 2021
Topic Review
Honokiol
Cancer is characterised by uncontrolled cell division and abnormal cell growth, which is largely caused by a variety of gene mutations. There are continuous efforts being made to develop effective cancer treatments as resistance to current anticancer drugs has been on the rise. Natural products represent a promising source in the search for anticancer treatments as they possess unique chemical structures and combinations of compounds that may be effective against cancer with a minimal toxicity profile or few side effects compared to standard anticancer therapy. Extensive research on natural products has shown that bioactive natural compounds target multiple cellular processes and pathways involved in cancer progression.
  • 785
  • 18 Aug 2021
Topic Review
ENDS, HTP and Lung
Electronic nicotine delivery systems (ENDS) and heated tobacco products (HTP) are sold by the tobacco industry as a safer alternative to conventional cigarettes with misleading marketing sustained by studies with conflict of interest. Research on these products found that damage produced by using these devices is involved in pathways related to pulmonary diseases, with  mechanisms previously reported in conventional cigarettes and new mechanisms particular to these devices, which challenges that the tobacco industry’s claims.
  • 781
  • 12 May 2021
Topic Review
Coherence Therapy
Coherence therapy is a system of psychotherapy based in the theory that symptoms of mood, thought and behavior are produced coherently according to the person's current mental models of reality, most of which are implicit and unconscious. It was founded by Bruce Ecker and Laurel Hulley in the 1990s. It has been considered among the most well respected postmodern/constructivist therapies.
  • 770
  • 29 Sep 2022
  • Page
  • of
  • 48
Video Production Service